Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease

Primary Care Respiratory Journal

Volumn 21, Issue 1, 2012, Pages 111-114

  Mir, Elias ^a   Shah, Ashok ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Allergic bronchopulmonary aspergillosis; Central bronchiectasis; Chronic obstructive pulmonary disease

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PRECIPITIN; PREDNISOLONE; TUBERCULOSTATIC AGENT;

ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTERIAL OXYGEN TENSION; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMORBIDITY; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DYSPNEA; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOPTYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG AUSCULTATION; LUNG CAPACITY; LUNG FUNCTION TEST; MALE; MEDICAL HISTORY; PRICK TEST; PROTEIN BLOOD LEVEL; SMOKING; SPUTUM VISCOSITY; THORAX RADIOGRAPHY; TREATMENT RESPONSE; WHEEZING;

EID: 85027950137     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00001     Document Type: Article

References (31)

1. Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010;7:237-44. http://dx.doi.org/10.1513/pats.200908-086AL
2. Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution. J Asthma 2002;39:273-89. http://dx.doi.org/10.1081/JAS-120002284
3. Laennec RTH. A treatise on the diseases of the chest. New York: Hafner Publishing; 1962.
4. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non smokers. Lancet 2009;374:733-43. http://dx.doi.org/10.1016/S0140-6736(09)61303-9
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504. http://dx.doi.org/10.1016/S0140-6736(96)07492-2
6. Elias J. The relationship between asthma and COPD; lessons from transgenic mice. Chest 2004;126:111S-116S. http://dx.doi.org/10.1378/chest.126.2_suppl_1.111S
7. Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses 2007;51:83-5.
8. Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, Jindal SK. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Medical Mycology 2010;48:988-94. http://dx.doi.org/10.3109/13693781003743148
9. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (Updated 2010). Accessed 25 March 2010 from: www.goldcopd.com
10. Chauhan B, Santiago L, Kirschmann DA, et al. The association of HLA DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997;159(8):4072-6.
11. Marchand E, Verellen-Dumoulin C, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-7. http://dx.doi.org/10.1378/chest.119.3.762
12. Brouard J, Knauer N, Boelle PY, et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis 2005;191:1988-91. http://dx.doi.org/10.1086/429964
13. Vaid M, Kaur S, Sambatakou H, Madan T, Denning DW, Sarma PU. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007;45:183-6. http://dx.doi.org/10.1515/CCLM.2007.033
14. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000;106:723-9. http://dx.doi.org/10.1067/mai.2000.109913
15. Orie NGM, Sluiter HJ, de Vries K, et al. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, eds. Bronchitis. Assen, the Netherlands: Royal van Gorcum, 1961;43-59.
16. Taylor RJ, Joyce H, Gross E, Holland F, Pride NB. Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers. Thorax 1985;40:9-16. http://dx.doi.org/10.1136/thx.40.1.9
17. Burrows B, Halonen M, Barbee RA, Lebowitz MD. The relationship of serum immunoglobulin E to cigarette smoking. Am Rev Respir Dis 1981;124:523-5.
18. Taylor RG, Gross E, Joyce H et al. Smoking, allergy and the differential white blood cell count. Thorax 1985;40:17-22. http://dx.doi.org/10.1136/thx.40.1.17
19. Brightling CE, Monteiro W, Ward R et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2000;356:1480-5. http://dx.doi.org/10.1016/S0140-6736(00)02872-5
20. Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997;155:1529-34.
21. Burrows B, Hasan FM, Barbee RA, et al. Epidemiologic observations on eosinophilia and its relation to respiratory disorders. Am Rev Respir Dis 1980;122:709-19.
22. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994;49:825-34. http://dx.doi.org/10.1136/thx.49.8.825
23. Pepys J, Riddell RW, Citron KM, Clayton YM, Short EI. Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis 1959;80:167-80.
24. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Wijngaerden EV. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;170:621-5. http://dx.doi.org/10.1164/rccm.200401-093OC
25. Maurya V, Gugnani HC, Sarma PU, Madan T, Shah A. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 2005;127:1252-9. http://dx.doi.org/10.1378/chest.127.4.1252
26. Kumar A, Shah A. Occurrence of upper airway symptoms and their impact on quality of life in patients with chronic obstructive pulmonary disease. Respirology 2008;13 (Suppl 5):A109.
27. Shah A. Allergic bronchopulmonary aspergillosis: an Indian perspective. Curr Opin Pulm Med 2007;13:72-80. http://dx.doi.org/10.1097/MCP.0b013e328011a284
28. Chakrabarti A, Sethi S, Raman DS, Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 2002; 45:295-9. http://dx.doi.org/10.1046/j.1439-0507.2002.00738.x
29. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-92.
30. Cerveri I, Dore R, Corsico A, et al. Assessment of emphysema in COPD: A functional and radiological study. Chest 2004;125:1714-18. http://dx.doi.org/10.1378/chest.125.5.1714
31. Madani A, Keyzer C, Gevenois PA. Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir J 2001;18:720-30. http://dx.doi.org/10.1183/09031936.01.00255701